List of Contents

U.S. Supplemental Health Market Size, Share, and Trends 2024 to 2033

U.S. Supplemental Health Market (By Product: Critical Illness Insurance, Accident Insurance, Hospital Indemnity Insurance, Worksite Life, Dental; By Distribution Channel: Direct-to-Consumer, Agents, Brokers, Others; By Demography: Individuals Aged 65 and Above, Individuals Aged Below 65 with an Eligible Disability) - Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033

  • Last Updated : June 2024
  • Report Code : 3063
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Supplemental Health Market 

5.1. COVID-19 Landscape: U.S. Supplemental Health Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Supplemental Health Market, By Product

8.1. U.S. Supplemental Health Market, by Product, 2023-2032

8.1.1 Critical Illness Insurance

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Accident Insurance

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Hospital Indemnity Insurance

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Worksite Life

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Dental

8.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 9. U.S. Supplemental Health Market, By Distribution Channel

9.1. U.S. Supplemental Health Market, by Distribution Channel, 2023-2032

9.1.1. Direct-to-Consumer (DTC)

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Agents

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Brokers

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. U.S. Supplemental Health Market, By Demography 

10.1. U.S. Supplemental Health Market, by Demography, 2023-2032

10.1.1. Individuals Aged 65 and Above

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Individuals Aged Below 65 with an Eligible Disability

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. U.S. Supplemental Health Market, country Estimates and Trends Forecast

11.1. U.S.

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

11.1.3. Market Revenue and Forecast, by Demography (2020-2032)

Chapter 12. Company Profiles

12.1. Aetna Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Allianz S.E.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. American International Group, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Anthem, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Assurant, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. AXA Group

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cigna Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Humana Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. MetLife, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Zurich Insurance Group AG

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client